Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edna Mozes

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Immunology|September 11, 2009
A tolerogenic peptide down-regulates mature B cells in bone marrow of lupus-afflicted mice by inhibition of interleukin-7, leading to apoptosisHava Ben-David, Amir Sharabi, Reshmi Parameswaran, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 25, 2007
The role of CD8+CD28 regulatory cells in suppressing myasthenia gravis-associated responses by a dual altered peptide ligandHava Ben-David, Amir Sharabi, Molly Dayan, et al.
Journal of Clinical Immunology|May 22, 2003
Lupus manifestations in severe combined immunodeficient (SCID) mice and in human/mouse radiation chimerasZev Sthoeger, Heidy Zinger, Benny Dekel, et al.
The Journal of Clinical Endocrinology and Metabolism|November 6, 2009
T cell responses to steroid cytochrome P450 21-hydroxylase in patients with autoimmune primary adrenal insufficiencyEirik Bratland, Beate Skinningsrud, Dag E Undlien, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2006
A 50-kDa ERK-like protein is up-regulated by a dual altered peptide ligand that suppresses myasthenia gravis-associated responsesHava Ben-David, Badiga Venkata Aruna, Rony Seger, et al.
Human Immunology|June 29, 2004
Immunomodulation by a dual altered peptide ligand of autoreactive responses to the acetylcholine receptor of peripheral blood lymphocytes of patients with myasthenia gravisMolly Dayan, Zev Sthoeger, Alex Neiman, et al.
European Journal of Immunology|October 20, 2006
The negative regulators Foxj1 and Foxo3a are up-regulated by a peptide that inhibits systemic lupus erythematosus-associated T cell responsesUri Sela, Molly Dayan, Rami Hershkoviz, et al.
Arthritis and Rheumatism|June 30, 2007
Altered gene expression in mice with lupus treated with edratide, a peptide that ameliorates the disease manifestationsAnat Elmann, Amir Sharabi, Molly Dayan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2007
The role of apoptosis in the ameliorating effects of a CDR1-based peptide on lupus manifestations in a mouse modelAmir Sharabi, Dror Luger, Hava Ben-David, et al.
Clinical Immunology (Orlando, Fla.)|July 28, 2009
A tolerogenic peptide that induces suppressor of cytokine signaling (SOCS)-1 restores the aberrant control of IFN-gamma signaling in lupus-affected (NZB x NZW)F1 miceAmir Sharabi, Zev M Sthoeger, Keren Mahlab, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Immunology|September 11, 2009
A tolerogenic peptide down-regulates mature B cells in bone marrow of lupus-afflicted mice by inhibition of interleukin-7, leading to apoptosisHava Ben-David, Amir Sharabi, Reshmi Parameswaran, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 25, 2007
The role of CD8+CD28 regulatory cells in suppressing myasthenia gravis-associated responses by a dual altered peptide ligandHava Ben-David, Amir Sharabi, Molly Dayan, et al.
Journal of Clinical Immunology|May 22, 2003
Lupus manifestations in severe combined immunodeficient (SCID) mice and in human/mouse radiation chimerasZev Sthoeger, Heidy Zinger, Benny Dekel, et al.
The Journal of Clinical Endocrinology and Metabolism|November 6, 2009
T cell responses to steroid cytochrome P450 21-hydroxylase in patients with autoimmune primary adrenal insufficiencyEirik Bratland, Beate Skinningsrud, Dag E Undlien, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2006
A 50-kDa ERK-like protein is up-regulated by a dual altered peptide ligand that suppresses myasthenia gravis-associated responsesHava Ben-David, Badiga Venkata Aruna, Rony Seger, et al.
Human Immunology|June 29, 2004
Immunomodulation by a dual altered peptide ligand of autoreactive responses to the acetylcholine receptor of peripheral blood lymphocytes of patients with myasthenia gravisMolly Dayan, Zev Sthoeger, Alex Neiman, et al.
European Journal of Immunology|October 20, 2006
The negative regulators Foxj1 and Foxo3a are up-regulated by a peptide that inhibits systemic lupus erythematosus-associated T cell responsesUri Sela, Molly Dayan, Rami Hershkoviz, et al.
Arthritis and Rheumatism|June 30, 2007
Altered gene expression in mice with lupus treated with edratide, a peptide that ameliorates the disease manifestationsAnat Elmann, Amir Sharabi, Molly Dayan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2007
The role of apoptosis in the ameliorating effects of a CDR1-based peptide on lupus manifestations in a mouse modelAmir Sharabi, Dror Luger, Hava Ben-David, et al.
Clinical Immunology (Orlando, Fla.)|July 28, 2009
A tolerogenic peptide that induces suppressor of cytokine signaling (SOCS)-1 restores the aberrant control of IFN-gamma signaling in lupus-affected (NZB x NZW)F1 miceAmir Sharabi, Zev M Sthoeger, Keren Mahlab, et al.
Pageof 6